Science & Enterprise subscription

Follow us on Twitter

  • A clinical trial is underway assessing a drug approved for a rare inherited disease as a treatment for people hospi… https://t.co/Jyaa0PlA4A
    about 57 mins ago
  • New post on Science and Enterprise: Trial Testing Rare Disease Drug for Covid-19 Pneumonia https://t.co/2hAsoiN16x #Science #Business
    about 60 mins ago
  • Discoveries in a university lab that enable detection of Covid-19 infections from a person's breath are being licen… https://t.co/DgmvR2EcTr
    about 17 hours ago
  • New post on Science and Enterprise: Breath Analysis Sensor Licensed to Detect Covid-19 https://t.co/IZh1x1rqfo #Science #Business
    about 17 hours ago
  • Seven new vaccine projects got underway last week, raising the total to 164, with six more vaccines reaching clinic… https://t.co/VvvPn7PGgu
    about 1 day ago

Please share Science & Enterprise

Covid-19 Vaccines, Therapies – 13 July 2020

Covid-19 vaccine and therapy tracker

BioRender Covid-19 vaccine and therapy tracker. (BioRender.com)

13 July 2020. A regular feature on Science & Enterprise each week is an update on Covid-19 therapies and vaccines in development. The report is provided by BioRender, in Toronto, Ontario, a company offering illustration and graphics tools for life sciences, biotechnology, and other disciplines.

This week’s report shows a marked increase in activity on therapies, while the number of vaccines in development and clinical trials increased only slightly from last week. The BioRender tracker shows 305 therapies for Covid-19 being developed, with 219 of those treatments in clinical trials, an increase of eight therapies each in development and trials. Vaccines, on the other hand, each added one new item in development and trials since last Monday.

In addition to the summary dashboard shown above, the BioRender Covid-19 vaccine and therapy page provides details of the vaccines and therapies, as well as an activity feed showing news updates on these drugs.

Last week, the U.S. politics publication Politico reported on the national arms race in Covid-19 vaccines, with each country trying to be the first to develop a vaccine to protect its population and capture the global market. You can read my assessment of the situation below, given yesterday on Twitter …

More from Science & Enterprise:

*     *     *

1 comment to Covid-19 Vaccines, Therapies – 13 July 2020